Jpmorgan Chase & Co »

Nkgen Biotech shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Nkgen Biotech (NKGN) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Nkgen Biotech

Tip: Access up to 7 years of quarterly data

All positions including Nkgen Biotech held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nkgen Biotech by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $12 31 0.39

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Ser 1 S&p Common (SPY)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Vanguard Index Fds S&p 500 Etf Common (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard Total Intl Bond Etf Fund (BNDX)
Broadcom Common (AVGO)
Exxon Mobil Corp Common (XOM)

View all positions for Jpmorgan Chase & Co

Top funds holding Nkgen Biotech

Polar Securities
University Of Chicago
Diametric Capital
Geode Capital Management
Citadel Advisors
Sequoia Financial Advisors
Vanguard Group
Northern Trust
BlackRock
State Street Corporation
Hrt Financial
Towneley Capital Management, Inc / DE
Tower Research Capital
BlackRock
Federation des caisses Desjardins du Quebec

View all funds holding Nkgen Biotech